András Balázs Dancsó

Title: **András Balázs Dancsó: Innovator in Neuropharmaceuticals**

Introduction

András Balázs Dancsó is a distinguished inventor based in Budapest, Hungary. With a focus on neuropharmaceuticals, Dancsó has made significant strides in the realm of drug formulation, contributing to advancements aimed at treating serious neurodegenerative and neurodevelopmental disorders.

Latest Patents

Dancsó holds one notable patent titled "Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form." This patent includes the development of zinc chloride co-crystals of racemic-(±)-blarcamesine hydrochloride, (S)-(−)-blarcamesine hydrochloride, and (R)-(+)-blarcamesine hydrochloride. The innovative processes outlined in the patent provide methods for preparing these co-crystals and pharmaceutical preparations intended for treating conditions such as Alzheimer's disease, Parkinson's disease dementia, and Rett syndrome.

Career Highlights

András Balázs Dancsó is currently employed at Egis Pharmaceuticals Ltd., a prominent player in the pharmaceutical industry. His work at this company has been pivotal in advancing his research and development capabilities, ultimately leading to impactful patent contributions.

Collaborations

In his pursuit of innovation, Dancsó collaborates with several talented individuals, including Zsuzsanna Szokol and Tamás Nagy. These collaborations foster a dynamic environment, allowing for the integration of diverse expertise and perspectives within the field.

Conclusion

András Balázs Dancsó exemplifies the spirit of innovation in the pharmaceutical industry, particularly in developing treatments for neurodegenerative and neurodevelopmental diseases. His patent contributions reflect his commitment to advancing healthcare solutions that address pressing medical challenges. With ongoing collaboration and research, Dancsó’s work continues to hold promise for improving patient outcomes in the future.